Eli Lilly and Company · 1 day ago
Advisor, Technology Transfer & Process Engineering
Indianapolis, IN
Full-time
Hybrid
Senior Level, Lead/Staff
$129K/yr - $209K/yr
10+ years expEli Lilly and Company is a global healthcare leader dedicated to improving lives through innovative medicines. As an Advisor in Technology Transfer and Process Engineering, you will play a crucial role in the technical operations and manufacturing of novel gene editing products, ensuring successful tech transfer and clinical manufacturing.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Drive technical readiness and on-site support for manufactures of mRNA and gRNA across early-stage and late-stage programs. This includes batch record writing and executed record review, process scale-up, process data trending and support of quality activities including change controls, deviation investigations, implementation of process improvements. Preference for candidates familiar with early- and late-stage experience in manufacturing
Oversee the manufacturing campaigns (on-site) at the CMO, including troubleshooting in close cooperation with the CMO and internal stakeholders. Travel to manufacturing sites will be required
Lead transfer efforts of active clinical processes to secondary vendors to drive supply chain robustness
Coordinate with Supply Chain on sourcing key components and raw materials to support a complex global drug product manufacturing network
Collaborate with cross-functional teams including Process Development, Formulation, Preclinical Toxicology, Analytical Development, Quality Control, Quality Affairs, and External Manufacturing
Write and provide technical review of GMP documents including tech transfer reports, best practices documents, SOPs, technical protocols, manufacturing batch records, campaign summary reports, etc
Write technical reports and contribute to global regulatory filings to support clinical development of Verve’s products
Qualification
Required
MS in engineering or related scientific field with 10+ years' relevant industry experience
Strong process chromatography experience required, across multiple modes of separation, column formats, scale-up, chromatography equipment, and column qualification
Gap assessment, relationship management, and organizational planning skills required. Ability to clearly communicate risks and potential impacts to both peer groups and management
Knowledge of GMP compliance around drug substance and drug product manufacturing. Understanding of differences in requirements between early-stage and late-stage programs
Attention to detail, critical analysis of data/reports, and troubleshooting abilities
Proven ability to take initiative to achieve results, keep projects on timeline, and find solutions as needed to ensure that project deliverables are met
Domestic and international travel required (25%)
Preferred
Additional experience with enzymatic reactions preferred
Preference for candidates with chromatography process development experience
Preference for candidates with plasmid production experience
Benefits
Company bonus
Eligibility to participate in a company-sponsored 401(k)
Pension
Vacation benefits
Eligibility for medical, dental, vision and prescription drug benefits
Flexible benefits (e.g., healthcare and/or dependent day care flexible spending accounts)
Life insurance and death benefits
Certain time off and leave of absence benefits
Well-being benefits (e.g., employee assistance program, fitness benefits, and employee clubs and activities)
Company
Eli Lilly and Company
We're a medicine company turning science into healing to make life better for people around the world.
10001+ employees
H1B Sponsorship
Eli Lilly and Company has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (514)
2024 (236)
2023 (167)
2022 (133)
2021 (57)
2020 (52)
Funding
Current Stage
Public CompanyTotal Funding
$6.5M2024-02-12Post Ipo Debt· $6.5M
1978-01-13IPO
Leadership Team
David Ricks
Chair, CEO
Lucas Montarce
Executive Vice President and Chief Financial Officer
Recent News
2026-01-08
2026-01-08
2026-01-08
Company data provided by crunchbase